Episurf’s implants approved for sale in Malaysia
Episurf Medical (NASDAQ: EPIS B) today announces that the Medical Device Authority (MDA) in Malaysia has approved the company’s implant technologies Episealer® Knee and Episealer® Talus for the Malaysian market. The approval follows a review process. “It is exciting to see the progress of the regulatory work for Episurf’s devices towards new markets. This regulatory approval opens up the market and enables us to work with our distributor towards the next important steps in Malaysia“, says Michael Näsström, Head of Quality and Regulatory Affairs at Episurf Medical.